Shanghai Sanyou Medical (SH:688085) Shang Hai Zheng Quan Bao·2025-08-13 18:43Core Viewpoint - The announcement details a share reduction plan by the actual controller of Shanghai Sanyou Medical Instrument Co., Ltd., Xu Nong, due to personal financial needs, involving a maximum reduction of 6,669,249 shares, which is 2.00% of the total share capital [3][19]. Summary by Sections Basic Information - As of the announcement date, Xu Nong's action partner, Chaos Tiancheng Asset Management - Xu Nong - Chaos Tiancheng Selected Strategy No. 18, holds 8,881,404 shares, accounting for 2.66% of the total share capital. Xu Nong directly holds 39,297,975 shares, while his action partners Michael Mingyan Liu and David Fan hold 30,341,922 shares and 16,335,114 shares, respectively. Collectively, these action partners hold 94,856,415 shares, representing 28.45% of the total [2]. Details of the Reduction Plan - Xu Nong plans to reduce his shares through block trading, with a maximum of 6,669,249 shares to be sold within three months starting from September 8, 2025, to December 7, 2025. The reduction will not exceed 2.00% of the total share capital, and any continuous 90-day reduction will also be limited to 2% of the total shares. If there are trading restrictions, the reduction will be paused [3][6]. Commitments by Shareholders - Xu Nong has made several commitments regarding shareholding, including not transferring or managing shares held before the public offering for 36 months and adhering to legal regulations regarding shareholding changes. He also commits to not reducing shares below the initial public offering price within two years after the lock-up period [8][11][14]. Compliance with Regulations - The reduction plan complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shanghai Stock Exchange's rules. The company and its shareholders will continue to monitor the plan's progress and fulfill disclosure obligations [19].